Related Experiment Video
Updated: Jan 31, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent
1Department of Bioorganic Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Umultowska 89b, 61‒614 Poznań, Poland.
Abstract:
Tumors are phenotypically heterogeneous and include a small sub-population of cancer cells (2-5% of the tumor mass) with stem-cell like properties. The cancer stem cell hypothesis postulates that the cancer stem cells (CSCs) show the ability to seed the tumor to distant tissues/organs, and their presence results in cancer progression and relapses. Extensive efforts have therefore been directed at new therapy strategies to eliminate not only non-CSCs, but also cancer cells with stem-cell like properties. Importantly, in 2009, the natural ionophore - salinomycin (SAL) was shown to be promising in this respect; SAL selectively and efficiently reduced the proportion of breast CSCs in vitro and in vivo. Since this original report, SAL has been shown to be active against numerous cancer cells and CSCs of different origin, including those that display multi-drug resistance. This concise review article is focused on the possible role of SAL in future cancer therapy.
Insights
Salinomycin (SAL) effectively targets cancer stem cells (CSCs), a small tumor subpopulation responsible for cancer progression and relapse. This review explores SAL
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Tumors exhibit phenotypic heterogeneity, containing a small fraction of cancer stem cells (CSCs).
- The cancer stem cell hypothesis links CSCs to tumor metastasis, progression, and recurrence.
- Targeting CSCs is crucial for developing effective cancer therapies.
Purpose of the Study:
- To review the therapeutic potential of salinomycin (SAL) against cancer stem cells.
- To explore SAL's efficacy across various cancer types and drug-resistant models.
- To discuss the future role of SAL in cancer treatment strategies.
Main Methods:
- Review of existing scientific literature on salinomycin and cancer stem cells.
- Analysis of in vitro and in vivo studies demonstrating SAL's effects on CSCs.
- Evaluation of SAL's activity against multi-drug resistant cancer cells.
Main Results:
- Salinomycin (SAL) selectively reduces breast cancer stem cells in vitro and in vivo.
- SAL exhibits activity against CSCs from diverse cancer origins.
- SAL demonstrates efficacy against multi-drug resistant cancer cells and CSCs.
Conclusions:
- Salinomycin shows significant promise as a therapeutic agent targeting cancer stem cells.
- SAL's broad-spectrum activity and effectiveness against resistant cancers warrant further investigation.
- SAL may play a key role in future cancer therapy strategies.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Social Cognitive Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality
Chemistry of Carbohydrates

